Search for companies, drugs, and catalysts
Phase 2
Development Phase
1
Upcoming Catalysts
0
Historical Events
Regulatory Approvals
RMC-6236 Phase 3 Results Expected
RMC-6236 • Colorectal Cancer
Target Indication
Colorectal Cancer
Clinical Trial
Last updated: 12/4/2025
RVMD
Revolution Medicines, Inc.